Septin‐5 and ‐7‐IgGs: Neurologic, Serologic, and Pathophysiologic Characteristics
- 27 August 2022
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 92 (6) , 1090-1101
Abstract
Background and Objectives: We sought to determine clinical significance of neuronal septin autoimmunity and evaluate for potential IgG effects.Methods: Septin‐IgGs were detected by indirect immunofluorescence assays (IFAs; mouse tissue and cell based) or Western blot. IgG binding to (and internalization of) extracellular septin epitopes were evaluated for by live rat hippocampal neuron assay. The impact of purified patient IgGs on murine cortical neuron function was determined by recording extracellular field potentials in a multielectrode array platform.Results: Septin‐IgGs were identified in 23 patients. All 8 patients with septin‐5‐IgG detected had cerebellar ataxia, and 7 had prominent eye movement disorders. One of 2 patients with co‐existing septin‐7‐IgG had additional psychiatric phenotype (apathy, emotional blunting, and poor insight). Fifteen patients had septin‐7 autoimmunity, without septin‐5‐IgG detected. Disorders included encephalopathy (11; 2 patients with accompanying myelopathy, and 2 were relapsing), myelopathy (3), and episodic ataxia (1). Psychiatric symptoms (≥1 of agitation, apathy, catatonia, disorganized thinking, and paranoia) were prominent in 6 of 11 patients with encephalopathic symptoms. Eight of 10 patients with data available (from 23 total) improved after immunotherapy, and a further 2 patients improved spontaneously. Staining of plasma membranes of live hippocampal neurons produced by patient IgGs (subclasses 1 and 2) colocalized with pre‐ and post‐synaptic markers. Decreased spiking and bursting behavior in mixed cultures of murine glutamatergic and GABAergic cortical neurons produced by patient IgGs were attributable to neither antigenic crosslinking and internalization nor complement activation.Interpretation: Septin‐IgGs are predictive of distinct treatment‐responsive autoimmune central nervous system (CNS) disorders. Live neuron binding and induced electrophysiologic effects by patient IgGs may support septin‐specific pathophysiology. ANN NEUROL 2022;92:1090–1101Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (NS120901, NS126227, NS115126)
This publication has 40 references indexed in Scilit:
- Two new cases of anti-Ca (anti-ARHGAP26/GRAF) autoantibody-associated cerebellar ataxiaJournal of Neuroinflammation, 2013
- Anti-ganglioside antibody internalization attenuates motor nerve terminal injury in a mouse model of acute motor axonal neuropathyJournal of Clinical Investigation, 2012
- Characterization of presynaptic septin complexes in mammalian hippocampal neuronsBiological Chemistry, 2011
- SeptinsCurrent Biology, 2011
- Altered Cortical CDC42 Signaling Pathways in Schizophrenia: Implications for Dendritic Spine DeficitsBiological Psychiatry, 2010
- Conquering the complex world of human septins: implications for health and diseaseClinical Genetics, 2010
- Neuronal expression of two isoforms of mouse Septin 5Journal of Neuroscience Research, 2009
- Sept5 deficiency exerts pleiotropic influence on affective behaviors and cognitive functions in miceHuman Molecular Genetics, 2009
- Role of Septin Cytoskeleton in Spine Morphogenesis and Dendrite Development in NeuronsCurrent Biology, 2007
- Septin 3 (G‐septin) is a developmentally regulated phosphoprotein enriched in presynaptic nerve terminalsJournal of Neurochemistry, 2004